Gregory Sargen

Insider Reports History

Entity
Individual
Signature
/s/ Mary Grendell, Attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Gregory Sargen:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Avid Bioservices, Inc. Director Restricted Stock Units 26.8K $165K $6.17 Dec 14, 2023 Direct
Avid Bioservices, Inc. Director Common Stock, $0.001 par value 9.61K $65.1K $6.77 Dec 14, 2023 Direct
Protara Therapeutics, Inc. Director Stock Option (Right to Buy) 10K Jun 7, 2024 Direct

Insider Reports Filed by Gregory Sargen

Symbol Company Period Transactions Value $ Form Type Date Filed Role
TARA Protara Therapeutics, Inc. Jun 7, 2024 1 $0 4 Jun 10, 2024 Director
CDMO Avid Bioservices, Inc. Dec 14, 2023 3 $0 4 Dec 18, 2023 Director
TARA Protara Therapeutics, Inc. Jun 7, 2023 1 $0 4 Jun 8, 2023 Director
CDMO Avid Bioservices, Inc. Apr 11, 2023 1 -$142K 4 Apr 12, 2023 Director
CDMO Avid Bioservices, Inc. Dec 14, 2022 3 $0 4 Dec 16, 2022 Director
TARA Protara Therapeutics, Inc. Jun 8, 2022 1 $0 4 Jun 9, 2022 Director
CDMO Avid Bioservices, Inc. Dec 14, 2021 3 $0 4 Dec 16, 2021 Director
TARA Protara Therapeutics, Inc. Jun 9, 2021 1 $0 4 Jun 10, 2021 Director